Resumen
Objetivo: Analizar los principales mecanismos neuroinflamatorios implicados en la fisiopatología del Trastorno de Estrés Postraumático (TEPT) y sus repercusiones clínicas. Revisión bibliográfica: El Trastorno de Estrés Postraumático es una condición psiquiátrica crónica desencadenada por la exposición a eventos traumáticos, caracterizada por alteraciones persistentes en los sistemas neuroendocrino, inmunológico y nervioso central. La evidencia reciente demuestra que la neuroinflamación desempeña un papel central en la fisiopatología del TEPT, siendo desencadenada por la activación de la microglía, el aumento de la permeabilidad de la barrera hematoencefálica y la liberación de citocinas proinflamatorias. Estos procesos favorecen la disfunción de neurotransmisores, entre ellos la serotonina, la dopamina, el glutamato, el ácido gamma-aminobutírico (GABA) y la noradrenalina, comprometiendo la plasticidad sináptica, la consolidación de la memoria y la regulación de las respuestas al estrés. Como consecuencia, se mantienen síntomas como la hipervigilancia, la reviviscencia, la evitación, las alteraciones del estado de ánimo y los déficits cognitivos, contribuyendo a la cronificación del trastorno. Consideraciones finales: La comprensión de los mecanismos neuroinflamatorios implicados favorece el desarrollo de estrategias capaces de modular la respuesta inflamatoria y restaurar la homeostasis neuroquímica, promoviendo abordajes terapéuticos más eficaces.
Referencias
ACOSTA SA, et al. Traumatic brain injury activates the adult hippocampal neurogenic niche and generates new neurons with altered morphology. Brain Injury. 2013; 27(7-8): 935-951.
AMERICAN PSYCHIATRIC ASSOCIATION. Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). 5th ed. Washington: American Psychiatric Association Publishing. 2022.
BARLATTANI F, et al. Gut microbiota, neuroinflammation and novel therapeutic strategies in post-traumatic stress disorder. Journal of Neuroinflammation. 2025; 22: 118.
BREMNER JD. Traumatic stress: effects on the brain. Dialogues in Clinical Neuroscience. 2006; 8(4): 445-461.
CHEN Y, et al. Advances in the pharmacological treatment of post-traumatic stress disorder: targeting neuroinflammation and oxidative stress. Frontiers in Pharmacology. 2021; 12: 712690.
DELL'OSTE V, et al. Peripheral inflammatory biomarkers in post-traumatic stress disorder: current evidence and future perspectives. Brain, Behavior, & Immunity – Health. 2023; 32: 100676.
DONG Y, et al. Microglial NLRP3 inflammasome contributes to fear memory impairment and anxiety-like behavior after traumatic stress. Brain, Behavior, and Immunity. 2020; 87: 273-287.
DOW JD, OBAID S. Neuroinflammation, oxidative stress, and blood-brain barrier dysfunction in post-traumatic stress disorder. Neuroscience & Biobehavioral Reviews. 2025; 168: 105962.
ENOMOTO M, et al. Involvement of microglia in disturbed fear memory regulation: Possible microglial contribution to the pathophysiology of posttraumatic stress disorder. Neurochemistry International. 2021; 142: 104921.
FONSECA R, et al. Neuroinflammation and microglial activation in post-traumatic stress disorder: an updated review. Brain, Behavior, & Immunity – Health. 2024; 37: 100772.
GOVINDULA A, et al. Emphasizing the Crosstalk Between Inflammatory and Neural Signaling in Post-traumatic Stress Disorder (PTSD). Journal of Neuroimmune Pharmacology. 2023; 18: 248-266.
HORI H, KIM Y. Inflammation and post-traumatic stress disorder. Psychiatry and Clinical Neurosciences. 2019; 73: 143-153.
KATRINLI S, et al. The role of the immune system in posttraumatic stress disorder. Translational Psychiatry. 2022; 12: 313.
LEE DH, et al. Neuroinflammation in post-traumatic stress disorder. Biomedicines. 2022; 10: 953.
LINDQVIST D, et al. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain, Behavior, and Immunity. 2014; 42: 81-88.
LIU YD, et al. PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation. Molecular Neurobiology. 2025; 62: 15318-15335.
PASSOS IC, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. The Lancet Psychiatry. 2015; 2(11): 1002-1012.
PERUZZOLO TL, et al. Inflammatory and oxidative stress markers in post-traumatic stress disorder: a systematic review and meta-analysis. Molecular Psychiatry. 2022; 27: 3150-3163.
SAH A, SINGEWALD N. The (neuro)inflammatory system in anxiety disorders and PTSD: potential treatment targets. Pharmacology & Therapeutics. 2025; 269: 108825.
WANG Z, et al. Neuroinflammation and synaptic dysfunction in post-traumatic stress disorder. Journal of Psychiatric Research. 2021; 141: 262-271.
ZUO C, et al. Dissecting the causal association between inflammation and post-traumatic stress disorder: A bidirectional Mendelian randomization study. Journal of Affective Disorders. 2023; 333: 436-445.
